Fundraising Fox

Versant Venture AIV Holdings

San Francisco

Fox Verdict
Sign up to see your fit

Fund manager profile

Versant Venture AIV Holdings is a venture fund manager based in San Francisco. SEC filings show 2 venture funds on record, most recently Versant Venture V AIV Feeder Holdings, L.P. ($5.3M offering) filed November 2016.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
San Francisco, US
Tracked investments
14

What they invest in

from 12 of 14 portfolio companies

Healthtech ×8Biotech ×6Medical Devices ×2Deep Tech ×1

HQs:United States×14

Investments · 14 tracked

founders shown can be your intro path
Edwards Lifesciencesin𝕏NYSE: EWSEC filingmedium confidence

BiotechHealthtechMedical DevicesIrvine, US

Nicholas J. Valeriani(Director)William J. Link(Director)Steven R. Loranger(Director)Donald E. Bobo, Jr.(Executive Officer)Wesley W. von Schack(Director)Scott B. Ullem(Executive Officer)

Board seatWilliam J. Link· per SEC Form D · $272.4M raise · filed Feb 2017

Lensarlensar.comNASDAQ: LNSRSEC filingmedium confidence

HealthtechOrlando, US

Lothar Koob(Director)Alan B Connaughton(Executive Officer)Amy R Brooks(Executive Officer)Charles W Federico(Director)Carmen L Bringgold(Director)Peter J Mariani(Executive Officer)

Board seatWilliam J. Link· per SEC Form D · $20M raise · filed May 2023

RxSight, Inc.NASDAQ: RXSTSEC filingmedium confidence

Aliso Viejo, US

Board seatWilliam Link· per SEC Form D · $77.5M raise · filed Apr 2017

Second Sight Medical ProductsNASDAQ: VANISEC filingmedium confidence

HealthtechSylmar, US

Edward Sedo(Acting Chief Accounting Officer)Matthew Pfeffer(Director)Scott Dunbar(Acting CEO)Gregg Williams(Director)Aaron Mendelsohn(Director)Jonathan Will McGuire(Director)

Board seatWilliam Link· per SEC Form D · $5M raise · filed Aug 2018

AcuFocus, Inc.acufocus.comSEC filingmedium confidence

BiotechIrvine, US

Alan Waterhouse(President and Chief Operating Officer)Buzz Benson(Director)Arjun Arora(Director)Jason Tester(Chief Financial Officer and Secretary)Richard L. Lindstrom, M.D.(Director)James Garvey(Director)

Board seatWilliam J. Link· per SEC Form D · $2M raise · filed Aug 2016

Allegro OphthalmicsSEC filingmedium confidence

BiotechSan Juan Capistrano, US

John Park(Executive Officer, Director)Hampar Karageozian(Member of Board of Managers and Chief Executive Officer)Marc D. Kirshbaum(Member of Board of Managers and Chief Operating Officer)A. Thomas Bender(Member of Board of Managers)Robert Byrnes(Member of Board of Managers)Vicken Karageozian(Member of Board of Managers and Chief Technical Officer)

Board seatWilliam LinkWilliam J. Link· per SEC Form D · $13.5M raise · filed Jan 2019

Equinox Ophthalmic, Inc.equinoxus.comSEC filingmedium confidence

HealthtechSioux Falls, US

RICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)

Board seatWilliam Link· per SEC Form D · $22M raise · filed Sep 2019

eyeBrain MedicalSEC filingmedium confidence

BiotechNewport Beach, US

Davis Corley(Executive Officer)

Board seatWilliam LinkWilliam T. Link· per SEC Form D · $15M raise · filed Jun 2022

OneFocus VisionSEC filingmedium confidence

HealthtechFernandina Beach, US

Warren Thaler(Director)William Link(Director)Ed Peterson(Director)Stephen Martin(Director)Steve Waite(Executive Officer, Director)

Board seatWilliam Link· per SEC Form D · $2.2M raise · filed Jul 2015

Oyster Point Pharma, Inc.oysterpointrx.comin𝕏SEC filingmedium confidence

Viatris develops and manufactures pharmaceutical products including generic medicines, branded pharmaceuticals, and over-the-counter therapies for global markets.

BiotechHealthtechSan Francisco, US

D. Michael Ackermann(Director)Mark A. Murray(Executive Officer, Director)William J Link(Director)Jeffrey Nau(Executive Officer, Director)Ali Behbahani(Director)

Board seatWilliam J Link· per SEC Form D · $43.1M raise · filed Oct 2017

Prelude CorpSEC filingmedium confidence

Laguna Hills, US

Board seatWilliam J. LinkWilliam Link· per SEC Form D · $5.5M raise · filed Mar 2017

Sightlife SurgicalSEC filingmedium confidence

HealthtechSeattle, US

TIM MCLAUGHLIN(Executive Officer)WILLIAM LINK(Director)KUSH PARIKH(Director)RICHARD LINDSTROM(Director)MONTY MONTOYA(Executive Officer, Director)MELODY SUMMERS(Director)

Board seatWilliam Link· per SEC Form D · $10M raise · filed Oct 2016

TearClearSEC filingmedium confidence

BiotechCopley, US

William Link(Director)Kevin Hershfield(Executive Officer, Director)Richard Heinick(Director)Steve Pazol(Director)Jeffry Weinhuff(Director)Tyler Stowater(Director)

Board seatWilliam Link· per SEC Form D · $4.6M raise · filed May 2017

ViaLasevialase.cominSEC filingmedium confidence

ViaLase develops a femtosecond laser system for noninvasive glaucoma treatment that creates apertures through the trabecular meshwork in open-angle glaucoma patients.

Deep TechHealthtechMedical DevicesAliso Viejo, US

Tibor Juhasz(Executive Officer, Director)Rick Lewis(Executive Officer)Scott Cooper(Executive Officer)Hadi Srass(Executive Officer)Shawn O'Neil(Executive Officer)

Board seatWilliam Link· per SEC Form D · $8.1M raise · filed Apr 2019

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

Where is Versant Venture AIV Holdings located?
Versant Venture AIV Holdings is headquartered in San Francisco, US.

Featured in lists